Commentary · 21 Feb 2026
Conference abstractPublished 17 Sep 2018
Cytotoxic, apoptotic and tumor regressive efficacy of polylactic-co-glycolic acid encapsulated diosgenin nanoparticles in cancer cell lines
Vidyasagar University, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is a universal public health problem as it is one of the main causes of morbidity and mortality worldwide. Polylacticco- glycolic acid (PLGA) nanoparticles, one of the most effective biodegradable polymeric nanoparticles, are approved by the US FDA to use for the encapsulation of various cancer-related drugs and their successful delivery in vivo due to its controlled and sustained release properties, low toxicity, and biocompatibility. Diosgenin (DGN), a steroidal saponin phytocompound, plays a predominant role in decreasing cell malignancy and inhibits tumor promotion reducing matrix metalloproteinases expression and inducing apoptosis through cell cycle arrest, activation of p53 and caspase-3 but DGN has many limitations in clinical application due to its poor solubility and low bioavailability. The present study was designed to synthesize PLGA encapsulated diosgenin nanoparticles (PLGA-DGN NPs) and to evaluate its anticancer efficacy. The PLGA-DGN nanoparticles exhibited high entrapment efficacy (73.8%), and a higher blood circulation half-time as well as sustained release kinetics, better bioavailability, and rapid intracellular uptake capability. PI and DAPI staining, cell cycle study by flow cytometry, DNA laddering, measurement of generation of reactive oxygen species using H2DCFDA stain, mitochondrial membrane potential by rhodamine 123 and Western blot analysis were performed to explore the pathways involved in the apoptosis. PLGA-DGN NPs showed cytotoxicity to MCF-7 and Ehrlich ascites carcinoma (EAC) cells without producing no toxicity to human and mouse lymphocytes. PLGA-DGN NPs induced apoptosis by elevating ROS, chromatin condensation, DNA fragmentation, cell cycle arrest, expression of proapoptotic proteins and mitochondrial dysfunction in MCF-7. The immunofluorescence studies of cytoskeletal and nuclear morphology revealed that after PLGA-DGN NPs treatment, the regular reorganization of actin filaments in MCF-7 cells became disrupted. In EAC-induced mouse solid tumor model, PLGA-DGN NPs significantly decreased cell proliferation, angiogenesis by reducing Ki-67 and CD-31 expression and the solid tumor were regressed and increased mean survival time of EAC-bearing mice was seen through the restoration of antioxidant status of the host mice. The findings confirm that PLGA-DGN NPs induced an antineoplastic effect that led to cell cycle arrest and apoptosis through the mitochondria-mediated intrinsic pathway and it is a promising anticancer nano-drug candidate for breast carcinoma.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Sujata Maiti Choudhury”
- BylineArticles whose byline prints “Surya Kanta Dey”
- BylineArticles whose byline prints “Ananya Pradhan”
